STVN
Stevanato Group SpANYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$3.76B
P/E Ratio
23.37
EPS
$0.59
Beta
0.62
52W High
$28.00
52W Low
$12.89
50-Day MA
$15.28
200-Day MA
$21.57
Dividend Yield
0.00%
Profit Margin
11.80%
Forward P/E
19.46
PEG Ratio
3.57
About Stevanato Group SpA
Stevanato Group SpA (STVN) is a leading global provider of advanced drug delivery systems, specializing in integrated solutions tailored for the pharmaceutical and biotechnology sectors. The company excels in the design and manufacturing of glass and polymer packaging for injectable medications, improving efficiency and reliability in the drug delivery process. With a strong commitment to quality and sustainability, Stevanato is well-positioned to benefit from the growing biopharmaceutical market, making it an attractive prospect for institutional investors looking to invest in healthcare innovation and technology advancement.
Fundamentals
| Revenue (TTM) | $1.19B |
| Gross Profit (TTM) | $346.20M |
| EBITDA | $283.56M |
| Operating Margin | 20.90% |
| Return on Equity | 9.67% |
| Return on Assets | 5.23% |
| Revenue/Share (TTM) | $4.35 |
| Book Value | $6.28 |
| Price-to-Book | 2.18 |
| Price-to-Sales (TTM) | 3.17 |
| EV/Revenue | 3.011 |
| EV/EBITDA | 12.57 |
| Quarterly Earnings Growth (YoY) | 0.30% |
| Quarterly Revenue Growth (YoY) | 4.80% |
| Shares Outstanding | $49.71M |
| Float | $48.95M |
| % Insiders | 1.58% |
| % Institutions | 108.21% |
Analyst Ratings
Consensus ($24.72 target)
2
Strong Buy6
Buy2
HoldData last updated: 4/9/2026